D.E. Shaw & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-48,200
Closed -$11M 4559
2023
Q4
$11M Buy
48,200
+37,200
+338% +$7.81M 0.01% 1297
2023
Q3
$2.21M Sell
11,000
-53,136
-83% -$11.2M ﹤0.01% 2483
2023
Q2
$13.3M Buy
64,136
+39,692
+162% +$7.7M 0.01% 1122
2023
Q1
$4.82M Sell
24,444
-11,640
-32% -$2.4M 0.01% 1960
2022
Q4
$7.3M Buy
36,084
+23,280
+182% +$4.55M 0.01% 1733
2022
Q3
$2.25M Buy
+12,804
New +$2.62M ﹤0.01% 2887
2020
Q4
Sell
-15,714
Closed -$2.54M 4042
2020
Q3
$2.54M Sell
15,714
-11,640
-43% -$1.84M ﹤0.01% 2215
2020
Q2
$3.9M Buy
27,354
+15,714
+135% +$2.17M ﹤0.01% 1852
2020
Q1
$1.26M Buy
+11,640
New +$1.68M ﹤0.01% 2556
2016
Q3
Sell
-38,063
Closed -$4.26M 3458
2016
Q2
$4.26M Hold
38,063
0.01% 1380
2016
Q1
$3.83M Buy
+38,063
New +$3.65M 0.01% 1451

Other funds holding LH

D.E. Shaw & Co's LH Position: Q2 2025 in Review

D.E. Shaw & Co sold out of Labcorp (LH) in Q2 2025, closing a stake of 31,376 shares — an estimated $7.3M sold.

D.E. Shaw & Co first reported a position in LH in Q4 2013 and held it in 44 quarters. The position peaked at $199M in Q1 2022. 973 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • D.E. Shaw & Co reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 31,376 Labcorp shares in Q2 2025, an estimated $7.3M.
  • D.E. Shaw & Co first reported a position in Labcorp in Q4 2013 and held it in 44 quarters.
  • D.E. Shaw & Co's Labcorp position peaked at $199M in Q1 2022.
  • 973 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.